Product Description
Sunscreening Agent
Mechanisms of Action: UV Blocker
Novel Mechanism: No
Modality: N/A
Route of Administration: N/A
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: Elanco Animal Health
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
---|---|---|---|---|---|
SPF Assay | N/A |
Completed |
Other |
2015-12-03 |
|
SPF Assay | N/A |
Completed |
Other |
2015-11-30 |
|
NCT02779270 | N/A |
Completed |
Sunburn |
2015-09-27 |